Listed by the USPTO as ELKINS, BLAKE HARRISON
Tech Center 1600 • Art Units: 1656 1684 1687
This examiner grants 100% of resolved cases
ELKINS, BLAKE HARRISON is assigned to tech center 1600 and art unit 1656. The profile contains 1 resolved case, an allowance rate of 100.0%, and a median of 1539 days to allowance. Interviews show a 0.0% lift in the allowance rate.
The single resolved case makes this an extremely limited record for forecasting future prosecution. That case reached allowance, but the available data does not establish a broader pattern. The interview figure provides no measured lift, so counsel should base interview decisions on the particular application and the issues presented by the examiner.
Tencent Technology (Shenzhen) Company Limited, Illumina Inc., and The Brigham and Women's Hospital Inc. are the leading companies. FOLEY & LARDNER LLP, OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., and 2SPL Patent Attorneys are the leading firms. These names identify the participants in the available record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18281025 | PROFILING EPIGENETIC AGE IN SINGLE CELLS AND WITH LOW-PASS SEQUENCING DATA | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17948695 | EXCRETA DETERMINATION METHOD, EXCRETA DETERMINATION DEVICE, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM STORING EXCRETA DETERMINATION PROGRAM | Final Rejection | PANASONIC HOLDINGS CORPORATION |
| 18559052 | ARTIFICIAL INTELLIGENCE-BASED METHOD FOR EARLY DIAGNOSIS OF CANCER, USING CELL-FREE DNA DISTRIBUTION IN TISSUE-SPECIFIC REGULATORY REGION | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 17960500 | METHOD FOR PREDICTING RETROSYNTHESIS OF A COMPOUND MOLECULE AND RELATED APPARATUS | Non-Final OA | TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED |
| 17956141 | CLINICAL OMICS DATA PROCESSING METHOD AND APPARATUS BASED ON GRAPH NEURAL NETWORK, DEVICE AND MEDIUM | Final Rejection | TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED |
| 17995250 | SYSTEMS AND METHODS FOR GUT MICROBIOME PRECISION MEDICINE | Final Rejection | The Regents of the University of California |
| 18343857 | METHODS FOR ASSESSING GENOMIC INSTABILITY | Non-Final OA | Life Technologies Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy100.0% of resolved applications examined by Blake Harrison Elkins were allowed (1 resolved cases), compared with 44.5% across Art Unit 1656 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Blake Harrison Elkins took 1,539 days on average from filing to allowance.
Blake Harrison Elkins examines applications in Art Unit 1656 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
